๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium

โœ Scribed by V. Vlahov; M. Badian; M. Verho; N. Bacracheva


Publisher
Springer
Year
1990
Tongue
English
Weight
487 KB
Volume
38
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics of fluvoxamine maleate
โœ M. H. De Vries; J. Van Harten; P. Van Bemmel; M. Raghoebar ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 286 KB ๐Ÿ‘ 2 views

The pharmacokinetics of fluvoxamine after single oral administration of 25, 50, and 100mg fluvoxamine maleate was studied in a three-way cross-over study in 12 healthy male subjects. Fluvoxamine was administered orally in a solution. For doseproportionality, AUC, and C,-dose relationships were evalu

Excretion of digoxin and its metabolites
โœ J. O. Magnusson; B. Bergdahl; C. Bogentoft; U. E. Jonsson; L. Tekenbergs ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 379 KB ๐Ÿ‘ 2 views

## Abstract The 3โ€day urinary excretion of digoxin, its conjugated and unconjugated hydrolytic metabolites and dihydrodigoxin, was studied in 8 healthy men after oral administration of tritiated digoxin. Analysis was performed by high pressure liquid chromatography (HPLC). The total radioactivity c

Single intravenous dose and steady-state
โœ John G. Wagner; Teck L. Ling; Edward J. Mroszczak; Donna Freedman; Ann Wu; Bee H ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 617 KB

Nicardipine HCI oral doses (10-40 mg) were administered sequentially to six healthy subjects. For each regimen the capsule dose was administered every 8 hours (q 8 h) for 3 days and the plasma profiles of nicardipine and its pyridine analogue (M5) were determined following the last dose on day 4. St

Pharmacokinetics of the active metabolit
โœ D. Beermann; H. G. Schaefer; M. Wargenau; B. Heibel; Y. Sturm; J. Kuhlmann ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 557 KB

The pharmacokinetics of BAY w 8199, the active metabolite of the prodrug repirinast (BAY u 2372), has been investigated after oral administration of 150, 300 and 450 mg repirinast to twelve healthy male Caucasians. Plasma BAY w 8199 concentrations were very variable between subjects. The mean peak l